68Ga-FAPI-04 Versus 18F-FDG PET/CT in a Case of Xanthogranulomatous Cholecystitis
Xanthogranulomatous cholecystitis (XGC) is an uncommon inflammatory disease of the gallbladder. We report a case of XGC with elevated activity of 18 F-FDG and 68 Ga-FAPI (fibroblast activating protein inhibitor), which mimics malignancy. Our case suggests that XGS should be considered in the differential diagnosis of cancer-like gallbladder lesions with increased 68 Ga-FAPI uptake.
Authors
- Yang Xie (ORCID: https://orcid.org/0000-0002-5666-3618)
- Yue Chen (ORCID: https://orcid.org/0000-0003-4088-7649)
- Xinyi Lin
Institutions
- Target (United States) (US)
- Southwest Medical University (CN)
- Affiliated Hospital of Southwest Medical University (CN)
Publication Details
- Journal
- Clinical Nuclear Medicine
- Published
- 2025-08-18
- DOI
- https://doi.org/10.1097/rlu.0000000000005984
- Citations
- 1
- Primary Topic
- Peptidase Inhibition and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 1.05